Trials / Completed
CompletedNCT02278211
Prediction of Recurrent Events With 18F-Fluoride
Prediction of Recurrent Events With 18F-Fluoride to Identify Ruptured and High-risk Coronary Artery Plaques in Patients With Myocardial Infarction
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 995 (actual)
- Sponsor
- University of Edinburgh · Academic / Other
- Sex
- All
- Age
- 50 Years
- Healthy volunteers
- Not accepted
Summary
This is a multi-centre observational study. It will make use of the positron emission tomography (PET) tracer 18F-sodium fluoride (18F-NaF) as a marker of coronary plaque vulnerability to detect culprit and non-culprit unstable coronary plaques in patients with recent myocardial infarctions. The investigators will then perform long-term follow-up of these patients to determine the prognostic significance of coronary 18F-NaF uptake
Detailed description
The investigators intend to recruit 700 patients hospitalised with myocardial infarction and proven multivessel coronary artery disease. All patients will undergo a combined CT coronary angiogram (CTCA) and PET scan using 18F-NaF as a tracer. Patients will then have clinical follow-up before undergoing a repeat CTCA at 2 years to assess progression of coronary disease. Clinical review of all patients will continue until study completion (given 2 years of recruitment this is likely to last 4 years) and following this the investigators will continue to monitor for further cardiovascular events via review of patient electronic health records for a further 5 years.
Conditions
Timeline
- Start date
- 2015-10-01
- Primary completion
- 2022-03-01
- Completion
- 2022-05-01
- First posted
- 2014-10-29
- Last updated
- 2025-03-17
- Results posted
- 2025-03-17
Locations
1 site across 1 country: United Kingdom
Source: ClinicalTrials.gov record NCT02278211. Inclusion in this directory is not an endorsement.